Last updated: May 5, 2025
Sponsor: National Cancer Institute, Egypt
Overall Status: Completed
Phase
N/A
Condition
N/ATreatment
Duloxetine and magnesium sulphate
Placebo and normal saline
placebo
Clinical Study ID
NCT06087211
AP2307-301-002
Ages 18-65 Female
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
Age from 18 to 65 years old.
American Society of Anesthesiologists (ASA) physical I-II
Scheduled for modified radical mastectomy (MRM) under general anesthesia.
Exclusion
Exclusion Criteria:
Liver or kidney disease
Patient with previous chronic pain on opioids
Patients on antidepressants and antipsychotics.
Allergies to study drugs
Study Design
Total Participants: 90
Treatment Group(s): 5
Primary Treatment: Duloxetine and magnesium sulphate
Phase:
Study Start date:
October 10, 2023
Estimated Completion Date:
January 01, 2025
Study Description
Connect with a study center
National cancer institute
Cairo, 11769
EgyptSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.